Log in

NYSE:TDOCTeladoc Health Stock Price, Forecast & News

$221.83
+12.61 (+6.03 %)
(As of 07/15/2020 04:00 PM ET)
Add
Compare
Today's Range
$203.34
Now: $221.83
$222.69
50-Day Range
$157.15
MA: $190.27
$228.98
52-Week Range
$54.58
Now: $221.83
$237.76
Volume2.39 million shs
Average Volume2.69 million shs
Market Capitalization$16.52 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.44
Teladoc Health, Inc. provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone. It serves employers, health plans, health systems, and other entities in approximately 100 countries worldwide. Teladoc Health, Inc. has a collaboration with Cincinnati Children's Hospital Medical Center to develop a consumer pediatric telehealth platform. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was founded in 2002 and is headquartered in Purchase, New York.
Read More
Teladoc Health logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.3Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.30 out of 5 stars


Industry, Sector and Symbol

Industry Offices & clinics of medical doctors
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone203-635-2002

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$553.31 million
Book Value$14.01 per share

Profitability

Net Income$-98,860,000.00

Miscellaneous

Employees2,400
Market Cap$16.52 billion
Next Earnings Date7/29/2020 (Confirmed)
OptionableOptionable

Receive TDOC News and Ratings via Email

Sign-up to receive the latest news and ratings for TDOC and its competitors with MarketBeat's FREE daily newsletter.

Teladoc Health (NYSE:TDOC) Frequently Asked Questions

How has Teladoc Health's stock been impacted by COVID-19 (Coronavirus)?

Teladoc Health's stock was trading at $137.40 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, TDOC shares have increased by 61.4% and is now trading at $221.83. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Teladoc Health?

27 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teladoc Health in the last year. There are currently 13 hold ratings and 14 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Teladoc Health.

When is Teladoc Health's next earnings date?

Teladoc Health is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for Teladoc Health.

How can I listen to Teladoc Health's earnings call?

Teladoc Health will be holding an earnings conference call on Wednesday, July 29th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Teladoc Health's earnings last quarter?

Teladoc Health Inc (NYSE:TDOC) posted its earnings results on Wednesday, April, 29th. The health services provider reported ($0.40) EPS for the quarter, missing the consensus estimate of ($0.35) by $0.05. The health services provider had revenue of $180.80 million for the quarter, compared to the consensus estimate of $180.64 million. Teladoc Health had a negative net margin of 16.24% and a negative return on equity of 10.60%. The company's quarterly revenue was up 40.6% on a year-over-year basis. During the same quarter last year, the business posted ($0.43) earnings per share. View Teladoc Health's earnings history.

What guidance has Teladoc Health issued on next quarter's earnings?

Teladoc Health issued an update on its second quarter 2020 After-Hours earnings guidance on Wednesday, April, 29th. The company provided EPS guidance of -0.28--0.23 for the period, compared to the Thomson Reuters consensus estimate of $-0.3. The company issued revenue guidance of $215-225 million, compared to the consensus revenue estimate of $182.26 million.

What price target have analysts set for TDOC?

27 equities research analysts have issued twelve-month target prices for Teladoc Health's shares. Their forecasts range from $80.00 to $280.00. On average, they anticipate Teladoc Health's share price to reach $176.46 in the next year. This suggests that the stock has a possible downside of 20.5%. View analysts' price targets for Teladoc Health.

Has Teladoc Health been receiving favorable news coverage?

Media headlines about TDOC stock have been trending positive on Thursday, InfoTrie Sentiment reports. The research firm rates the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Teladoc Health earned a coverage optimism score of 2.1 on InfoTrie's scale. They also assigned media stories about the health services provider a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the company's share price in the near term. View the latest news about Teladoc Health.

Who are some of Teladoc Health's key competitors?

What other stocks do shareholders of Teladoc Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teladoc Health investors own include NVIDIA (NVDA), Alibaba Group (BABA), Shopify (SHOP), Advanced Micro Devices (AMD), Netflix (NFLX), Walt Disney (DIS), Trade Desk (TTD), Square (SQ), salesforce.com (CRM) and Paypal (PYPL).

Who are Teladoc Health's key executives?

Teladoc Health's management team includes the following people:
  • Mr. Jason Nathanial Gorevic, CEO & Director (Age 47)
  • Mr. Peter A. McClennen, Pres & Interim COO (Age 50)
  • Mr. Adam Christian Vandervoort, Chief Legal Officer & Sec. (Age 44)
  • Ms. Stephany Verstraete, Chief Marketing Officer (Age 50)
  • Dr. George Byron Brooks BS EE, M.D., Co-Founder

When did Teladoc Health IPO?

(TDOC) raised $112 million in an initial public offering (IPO) on Wednesday, July 1st 2015. The company issued 7,000,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities served as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

What is Teladoc Health's stock symbol?

Teladoc Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "TDOC."

Who are Teladoc Health's major shareholders?

Teladoc Health's stock is owned by many different institutional and retail investors. Top institutional shareholders include Riverbridge Partners LLC (0.84%), Scout Investments Inc. (0.14%), Envestnet Asset Management Inc. (0.13%), Spence Asset Management (0.05%), Carnegie Capital Asset Management LLC (0.04%) and Meridian Wealth Management LLC (0.02%). Company insiders that own Teladoc Health stock include Adam C Vandervoort, Andrew Turitz, David L Shedlarz, Gabriel R Cappucci, Jason N Gorevic, Kenneth H Paulus, Lewis Levy, Mala Murthy, Mark Hirschhorn, Michael Goldstein, Michelle Bucaria, Peter A Mcclennen, Stephany Verstraete and William H Frist. View institutional ownership trends for Teladoc Health.

Which major investors are selling Teladoc Health stock?

TDOC stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Spence Asset Management, Wesbanco Bank Inc., Gradient Investments LLC, Legacy Capital Partners Inc., Carnegie Capital Asset Management LLC, Buckley Wealth Management LLC, and Teamwork Financial Advisors LLC. Company insiders that have sold Teladoc Health company stock in the last year include Adam C Vandervoort, Andrew Turitz, David L Shedlarz, Gabriel R Cappucci, Jason N Gorevic, Kenneth H Paulus, Lewis Levy, Mala Murthy, Michael Goldstein, Michelle Bucaria, Peter A Mcclennen, Stephany Verstraete, and William H Frist. View insider buying and selling activity for Teladoc Health.

Which major investors are buying Teladoc Health stock?

TDOC stock was purchased by a variety of institutional investors in the last quarter, including Scout Investments Inc., Secure Asset Management LLC, DNB Asset Management AS, Empowered Funds LLC, IFM Investors Pty Ltd, Wedbush Securities Inc., Meridian Wealth Management LLC, and Envestnet Asset Management Inc.. View insider buying and selling activity for Teladoc Health.

How do I buy shares of Teladoc Health?

Shares of TDOC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Teladoc Health's stock price today?

One share of TDOC stock can currently be purchased for approximately $221.83.

How big of a company is Teladoc Health?

Teladoc Health has a market capitalization of $16.52 billion and generates $553.31 million in revenue each year. The health services provider earns $-98,860,000.00 in net income (profit) each year or ($1.49) on an earnings per share basis. Teladoc Health employs 2,400 workers across the globe.

What is Teladoc Health's official website?

The official website for Teladoc Health is www.teladoc.com.

How can I contact Teladoc Health?

Teladoc Health's mailing address is 2 MANHATTANVILLE ROAD SUITE 203, PURCHASE NY, 10577. The health services provider can be reached via phone at 203-635-2002 or via email at [email protected]

This page was last updated on 7/16/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.